Oxylobio
OxyLo develops enzyme-based microcapsule therapies delivered locally to solid tumors to improve therapeutic efficacy. This platform concentrates therapeutic activity inside the tumor, minimizing systemic off-target toxicity. The technology supports programs like HypoxyCaps for metabolic disruption and ProCaps for local prodrug activation.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- OxyLo develops enzyme-based microcapsule therapies delivered locally to solid tumors to improve therapeutic efficacy. This platform concentrates therapeutic activity inside the tumor, minimizing systemic off-target toxicity. The technology supports programs like HypoxyCaps for metabolic disruption and ProCaps for local prodrug activation.